Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and NK Cell Activity in Colorectal Surgery
NCT01841294Phase 4Unknown
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in colorectal cancer (CRC), sponsored by Hôpital Maisonneuve-Rosemont. Primary endpoint: Natural Killer cell activity at 3 days. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01841294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841294.